Download PDF
1 / Pages

Other users also viewed these articles

Chronic kidney disease progression in patients with resistant hypertension subject to 2 therapeutic strategies: Intensification with loop diuretics vs aldosterone antagonists U. Verdalles; M. Goicoechea; S. García de Vinuesa; E. Torres; A. Hernández; E. Verde; A. Pérez de José; J. Luño;
Nefrologia (English Version). 2020;40:66-74
Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology Aleix Cases; Jose Jesus Broseta; Maria Marqués; Secundino Cigarrán; Juan Carlos Julián; Roberto Alcázar; Alberto Ortiz;
Nefrologia (English Version). 2024;44:771-83
Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients Luis Alberto Vigara; Florentino Villanego; Cristhian Orellana; Myriam Eady; María Gabriela Sánchez; Marta Alonso; María Belén García; José Manuel Amaro; Teresa García; Auxiliadora Mazuecos;
Nefrologia (English Version). 2024;44:885-93